Pharma giants gaining big in 2022

Pharma giants gaining big in 2022

International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
Are M&As still a top trend in the pharma market?

Are M&As still a top trend in the pharma market?

After a significant decrease in the value of mergers and acquisitions (M&As) in Vietnam in 2018-2020, such activities have recovered in the past year. Ngo Thanh Hai and Nguyen Dieu Quynh from LNT & Partners offer their insight into the current M&A trend in the local pharmaceutical market.
Overseas touch lends to pharma gains

Overseas touch lends to pharma gains

Vietnam’s pharma giants are growing with new strategies from foreign leadership, easing local doubts over the possible disappearance of local strong brands.
Encouragement given for pharma revolution

Encouragement given for pharma revolution

While Vietnam’s pharmaceutical and healthcare industries are waiting for a big push to shine, with potential trends to focus on import and production of vaccines and tech transfer, foreign enterprises continue to seek more adjustments of legal barriers.
Top pharma groups bet on high growth

Top pharma groups bet on high growth

A decade of innovation is in sight for Vietnam’s largest pharmaceutical companies, as long as quick adaption and changes in business strategy are carried out.
AstraZeneca - Pioneering sustainability across full span of global pharma operations

AstraZeneca - Pioneering sustainability across full span of global pharma operations

With strong commitments and efforts to reduce greenhouse gas emissions globally, AstraZeneca is pioneering the Net-Zero Corporate Standard of the new Science Based Targets initiative in the pharmaceutical industry. Nitin Kapoor, chairman and general director of AstraZeneca Vietnam, discussed with Thuy Nguyen the company’s sustainable development strategy and its contribution to the sustainable growth of healthcare in Vietnam.
Pharma giants beat revenue expectations

Pharma giants beat revenue expectations

Pharmaceutical companies like Pfizer, Novartis, Roche, and GSK performed well in the first three quarters of 2021, with plans to venture further into the lucrative Vietnamese market.
New race begins with COVID-19 oral medications

New race begins with COVID-19 oral medications

Together with vaccines, multinational corporations are on the journey to make oral antiviral medication for the treatment of COVID-19, expecting to bring new innovation for infections and promising profitable years for pharma giants.
Pharma drive a chance for real estate

Pharma drive a chance for real estate

Despite having limited facilities for life sciences real estate, Vietnam could open up to potential development in the industry, analysts say.
More time and effort required for EVFTA-led pharma advances

More time and effort required for EVFTA-led pharma advances

The EU-Vietnam Free Trade Agreement (EVFTA) officially took effect in August 2020, opening tremendous prospects in the comprehensive partnership between the two.
EVFTA effect yet to blossom in pharma

EVFTA effect yet to blossom in pharma

While encouraging signs bring some hope for European players in the enforcement of the EU-Vietnam Free Trade Agreement, more conundrums are still to be solved to increase attraction for the local pharmaceutical market.
Pharma rules unable to stand test of time

Pharma rules unable to stand test of time

After four years of enforcement of certain pharmaceutical rules, multinational corporations remain concerned and are changing operations in Vietnam, with import being one of the main focuses.
Targets being tweaked by prepared pharma

Targets being tweaked by prepared pharma

There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
Japan’s health names latch onto Vietnam

Japan’s health names latch onto Vietnam

More Japanese pharma and healthcare companies are heading to Vietnam as drug demands in the local lucrative market are on the rise.
Pharma groups redouble patient-centric efforts

Pharma groups redouble patient-centric efforts

Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
|< < 1 2 3 4 > >|